Inferior vena CAVA and lung ultraSound-guided therapy in acute heart failure: A randomized pilot study (CAVAL US-AHF study).
Lucrecia María BurgosRocio Consuelo Baro VilaFranco Nicolás BallariAilin GoyenecheJuan Pablo CostabelFlorencia MuñozAna SpaccaventoMartín Andrés FasanLucas Leonardo SuárezMartin VivasLaura RiznykSebastian GhibaudoMarcelo TriviRicardo RonderosFernando BottoMirta Dieznull nullPublished in: American heart journal (2024)
IVC and lung ultrasound-guided therapy in AHF patients significantly reduced subclinical congestion at discharge. CAVAL US-AHF provides preliminary evidence for the potential use of a simple technique to guide decongestive therapy during hospitalization for AHF, which may reduce the composite outcome at 90 days.
Keyphrases
- inferior vena cava
- ultrasound guided
- pulmonary embolism
- vena cava
- acute heart failure
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- ejection fraction
- stem cells
- prognostic factors
- fine needle aspiration
- mesenchymal stem cells
- peritoneal dialysis
- patient reported outcomes
- cell therapy
- bone marrow
- smoking cessation